News Releases

First vaccine for bovine coronavirus (BCoV), to protect newborn calves against respiratory disease MADISON, NJ, APRIL 4, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the European Commission granted marketing authorization for BOVILIS® Nasalgen®-C, a bovine coronavirus (BCoV) vaccine for cattle. The intranasal, live vaccine can […]

Read more

Virtual event featuring 12 global experts offered free to veterinary professionals MADISON, N.J., March 16, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the company will host a virtual continuing education symposium featuring 12 experts from around the world. This event, sponsored by NOBIVAC® will be […]

Read more

Winning veterinary student sets out to examine canine tick-borne diseases in Nepal MADISON N.J., February 23, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the inaugural recipient of the World Small Animal Veterinary Association (WSAVA) Michael J. Day Scholarship, Somnath Aryal. Aryal, a Nepalese veterinary student […]

Read more

Dutch Minister Micky Adriaansens attends official facility opening Facility capacity to meet increased global customer demand for our innovative vaccines BOXMEER, the Netherlands, Jan. 23, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the opening of a state-of-the-art manufacturing facility in Boxmeer, the Netherlands, for […]

Read more

Innovative single-dose topical treatment proven to safely and effectively treat clinical signs associated with otitis externa in dogs MADISON, N.J., USA, October 24, 2022– MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Medicines Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) issued a […]

Read more

Through its Afya Program, MSD Animal Health Is Committed to the United Against Rabies collaboration’s “Zero by 30” Rabies Elimination Goal MADISON, N.J., Sept. 28, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK), announced on World Rabies Day that it has now donated more than five million […]

Read more

Digital swine traceability solution tracks swine throughout their lifecycle Investment complements MSD Animal Health’s broad portfolio of veterinary pharmaceuticals, vaccines and technology solutions MADISON, N.J., Sept. 27, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced that it has completed a minority investment in LeeO Precision Farming […]

Read more

Virtual fencing system provides advanced technology to cattle producers and ranchers to manage natural resources more effectively Complements MSD Animal Health’s broad portfolio of veterinary pharmaceuticals, vaccines and animal intelligence solutions MADISON, N.J., Sept. 22, 2022 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced that it has […]

Read more

Preliminary results of field study found 73% of farms tested positive for BCoV BCoV associated with increased risk for Bovine Respiratory Disease (BRD), one of the most common and costly diseases in calves Madison, N.J., Sept. 5, 2022– MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today preliminary […]

Read more